Showing 51-60 of 308 results for "".
Updates from the AAD Annual Meeting in San Diego
https://practicaldermatology.com/topics/practice-management/updates-from-the-aad-annual-meeting-in-san-diego/18332/From cosmetic interventions to therapeutic breakthroughs for common dermatoses, and new technologies for practice, the latest innovations take center stage at the 2018 Annual Meeting of the American Academy of Dermatology. Joel L. Cohen, MD; Yolanda Lenzy, MD, MPH; Junko Takeshita, MD, PhD, MSCE; anSDPA: Sara Wilchowski Talks About Transitioning to Industry and Understanding How Nutraceuticals Can Help Patients
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-sara-wilchowski-talks-about-transitioning-to-industry-and-understanding-how-nutraceuticals-can-help-patients/29513/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with Sara Wilchowski, DMSc, MPAS, PA-C. Wilchowski is currently a senior medical science liaison and joined a panel of MSLs to discuss the ins and outs of transitioning to industry. Following the panel, she gave a lBellafill Fills a Niche; Soolantra Targets Rosacea
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-bellafill-fills-a-niche-soolantra-targets-rosacea-/18995/In this edition of DermWireTV from the editors of Practical Dermatology® magazine, a look at the approval of Bellafill (Suneva) to treat acne scars and Soolantra (Ivermectin 1%, Galderma) to treat rosacea. Plus, Benzac (Galderma) is now available OTC to treat acne, and Opdivo (Bristol-Myers Squibb)DERM2021: An Engaging Learning Experience
https://practicaldermatology.com/series/dermatology-education-foundation/derm2021-an-engaging-learning-experience/19967/Joe Gorelick, MSN, FNP-BC, DEF President, is excited for this year’s DERM2021 NP/PA CME Conference that offers meaningful case studies presented by an advisory panel of dermatology nurse practitioners and physician assistants for an engaging learning experience.Psoriasis Update 2025: Dr. Gelfand
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/psoriasis-update-2025-dr-gelfand/32672/Joel Gelfand, MD, MSCE, discusses highlights from the "Psoriasis Update 2025" panel at Maui Derm 2025, including the potential for combining TNF inhibitors with IL-23 inhibitors; home phototherapy; and the possibility of GLP-1 agonists lowering the severity of psoriatic disease.Live in Las Vegas: Get Ready for DERM2021
https://practicaldermatology.com/series/dermatology-education-foundation/live-in-las-vegas-get-ready-for-derm2021/19968/The DERM2021 NP/PA CME Conference offers dermatology physician assistants and nurse practitioners an opportunity to stay up to date on the latest products, drugs, and treatments in dermatology to improve care for patients. Joe Gorelick, MSN, FNP-BC, DEF President, says this year’s conference is goinCombatting Disparities in Dermatology
https://practicaldermatology.com/topics/general-topics/combatting-disparities-in-dermatology/18338/Research shows disparities in dermatology exisit. Junko Takeshita, MD, PhD, MSCE discusses some examples, such as racial disaparities in which patients recieve biolgics to treat severe psoriasis. She also shares tips on how to determine what implicit biases you may have to race, gender, weight, etc.Learn More About REVIAN® Red Hair Growth System
https://practicaldermatology.com/topics/hair-nails/learn-more-about-revian-red-hair-growth-system/19750/Discover a new option for hair loss patients! REVIAN Red is a patented dual-band LED wireless cap for at-home use ten minutes daily. Click Here to Become a REVIAN Red Professional. REVIAN Red is indicated to treat androgenetic alopecia and to promote hair growth in males who have Norwood-Hamilton clAnalyzing Safety Data From Level Up
https://practicaldermatology.com/series/the-practical-dermatology-podcast/analyzing-safety-data-from-level-up/33944/The latest news and updates, plus Matthew Zirwas, MD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss the importance of the Week 16 safety data from the Level Up study on upadacitinib. Silverberg JI, Bunick CG, et al. Efficacy and safety of upadacitinib versuExploring the Benefits of Nitric Oxide for Hair Loss Patients Through REVIAN® Red
https://practicaldermatology.com/topics/hair-nails/exploring-the-benefits-of-nitric-oxide-for-hair-loss-patients-through-revian-red/19753/Learn more about the mechanism of action of the new REVIAN Red Dual-Band LED light therapy cap and what makes it unique from other at-home FDA-cleared devices. REVIAN Red is indicated to treat androgenetic alopecia and to promote hair growth in males who have Norwood-Hamilton classifications of IIa